E. V. Kudryashov

发表

Outpatient Registry REGION: Prospective Follow-up Data and Outcomes in Patients After Acute Cerebrovascular Accident

S. Boytsov, O. Drapkina, S. Martsevich, 2020 .

Young ambulatory patients with cardiovascular diseases: age and gender characteristics, comorbidity, medication and outcomes (according to RECVASA register)

S. Boytsov, O. Drapkina, S. Yakushin, 2019, Cardiovascular Therapy and Prevention.

The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries)

V. P. Mikhin, S. Boytsov, O. Drapkina, 2019, Rational Pharmacotherapy in Cardiology.

ORAL ANTICOAGULANTS IN AMBULATORY AND IN-HOSPITAL TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION ASSOCIATED WITH HYPERTENSION, ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE: DATA FROM HOSPITAL REGISTRY RECVASA-CLINIC

S. Boytsov, M. Loukianov, E. V. Kudryashov, 2017 .

Cardiovascular Diseases and Drug Treatment in Patients with the History of Cerebral Stroke: Data of the Outpatient Registry REGION

S. Boytsov, O. Drapkina, S. Martsevich, 2019, Rational Pharmacotherapy in Cardiology.

Patients with Premature Cardiovascular Diseases in Ambulatory Practice: Demographic Characteristics, Risk Factors and Adherence to the Medical Therapy (Data of RECVASA Registry)

S. Boytsov, O. Drapkina, S. Yakushin, 2020 .

Patients with History of Myocardial Infarction and Acute Cerebrovascular Accidentin Clinical Practice: Demographic, Clinical Characteristics, Drug Treatment and Outcomes (Data of Outpatient and Hospital Registry REGION)

S. Boytsov, O. Drapkina, S. Martsevich, 2019, Rational Pharmacotherapy in Cardiology.

Early cardiovascular multimorbidity in out- and in-patient care: age characteristics and medication therapy (data from the REKVAZA and REKVAZA-CLINIC registries)

A. A. Smirnov, S. Boytsov, O. Drapkina, 2020, Cardiovascular Therapy and Prevention.

Patients with Combination of Cardiovascular Diseases and Type 2 Diabetes in RECVASA and REGION Registries: Multimorbidity, Outcomes and Potential Effect of Dapagliflozin in the Russian Clinical Practice

A. Kontsevaya, A. Kontsevaya, M. Loukianov, 2020 .

Combination of Atrial Fibrillation and Coronary Heart Disease in Patients in Clinical Practice: Comorbidities, Pharmacotherapy and Outcomes (Data from the REСVASA Registries)

V. P. Mikhin, S. Boytsov, O. Drapkina, 2021, Rational Pharmacotherapy in Cardiology.

Clinical and anamnestic characteristics and comorbidity in patients after myocardial infarction with and without arterial hypertension (data from the RECVASA-CLINIC registry)

O. Drapkina, E. V. Kudryashov, M. M. Lukyanov, 2019, Profilakticheskaya meditsina.

Patients with Atrial Fibrillation in Clinical Practice: Comorbidity, Drug Treatment and Outcomes (Data from RECVASA Registries)

V. P. Mikhin, S. Boytsov, O. Drapkina, 2020, Rational Pharmacotherapy in Cardiology.

COMPARATIVE CHARACTERISTICS OF MULTIMORBIDITY, DRUG TREATMENT AND OUTCOMES IN POSTSTROKE PATIENTS WITH ATRIAL FIBRILLATION AND WITH OR WITHOUT HISTORY OF MYOCARDIAL INFARCTION (REGISTRY REGION DATA)

S. Boytsov, O. Drapkina, S. Yakushin, 2020, Atherothrombosis.

Experience of creating and the first results of the prospective hospital registry of patients with suspected or confirmed coronavirus infection (COVID-19) and community-acquired pneumonia (TARGET-VIP)

A. A. Smirnov, O. Drapkina, A. Pulin, 2020 .

Detection rate and characteristics of heart failure, depending on the diagnostic criteria in COVID-19 survivors one year after hospitalization

A. A. Smirnov, A. Pulin, S. Martsevich, 2023, Cardiovascular Therapy and Prevention.

Long-term outcomes in patients after COVID-19: data from the TARGET-VIP registry

A. A. Smirnov, O. Drapkina, A. Pulin, 2022, Russian Journal of Cardiology.

Prehospital Period in Patients with COVID-19: Cardiovascular Comorbidity and Pharmacotherapy During the First Epidemic Wave (Hospital Registry Data)

A. A. Smirnov, O. Drapkina, S. Martsevich, 2022, Rational Pharmacotherapy in Cardiology.

THE STUDY "REGISTER OF PATIENTS AFTER ACUTE STROKE (REGION)". PART 2. OUTPATIENT PROSPECTIVE REGISTER OF PATIENTS AFTER ACUTE STROKE (ACCORDING TO THE RESULTS OF THE PILOT PHASE OF THE STUDY)

A. Deev, S. Boytsov, S. Martsevich, 2016 .

Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19

A. A. Smirnov, A. Pulin, S. Martsevich, 2022, Rational Pharmacotherapy in Cardiology.

CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA)

A. Deev, S. Boytsov, S. Martsevich, 2016 .

Patients with a Combination of Atrial Fibrillation and Chronic Heart Failure in Clinical Practice: Comorbidities, Drug Treatment and Outcomes

V. P. Mikhin, S. Boytsov, O. Drapkina, 2022, Rational Pharmacotherapy in Cardiology.

PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, -BLOCKERS AND ADHERENCE TO THE DRUG THERAPY (DATA OF OUTPATIENT REGISTRY RECVASA)

A. Deev, S. Boytsov, S. Martsevich, 2017 .